How has been the historical performance of Entero Healthcar?

Sep 01 2025 10:46 PM IST
share
Share Via
Entero Healthcar has shown significant growth from March 2021 to March 2025, with net sales increasing from 1,779.74 crore to 5,095.78 crore and a turnaround from losses to a profit of 107.43 crore after tax. The company has improved its operating profit and earnings per share, indicating a strong recovery and positive financial trajectory.
Answer:
The historical performance of Entero Healthcar shows significant growth over the years, particularly from March 2021 to March 2025.

Breakdown:
Entero Healthcar's net sales have increased from 1,779.74 crore in March 2021 to 5,095.78 crore in March 2025, reflecting a strong upward trend. Total operating income has followed a similar trajectory, rising from 1,779.74 crore to 5,095.78 crore during the same period. The company's total expenditure has also grown, from 1,758.19 crore in March 2021 to 4,924.23 crore in March 2025, but operating profit (PBDIT) has improved significantly, moving from 25.48 crore to 211.06 crore. Profit before tax has transitioned from a loss of 10.84 crore in March 2021 to a profit of 138.74 crore in March 2025, while profit after tax has turned from a loss of 15.35 crore to a profit of 107.43 crore. The consolidated net profit has seen a remarkable recovery, increasing from a loss of 15.54 crore in March 2021 to a profit of 94.82 crore in March 2025. The company's earnings per share have also improved significantly, from -1554.0 in March 2021 to 21.79 in March 2025. On the balance sheet, total assets have grown from 748.97 crore in March 2021 to 2,688.21 crore in March 2025, while total liabilities increased from 835.64 crore to 2,688.21 crore. Cash flow from operating activities has remained negative but improved from -68.00 crore in March 2021 to -76.00 crore in March 2025, with cash flow from investing activities showing a positive shift in March 2025 at 232.00 crore, compared to negative figures in previous years. Overall, Entero Healthcar has demonstrated a strong recovery and growth trajectory over the past five years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News